Ionis’ drug, called sapablursen, is currently being tested in a Phase 2 trial in people with polycythemia vera.
During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of multiple myeloma after quadruplet frontline with transplant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback